Analysis of the 5HT-2A T102C receptor polymorphism and psychotic symptoms in Alzheimer's disease

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 144, Issue 1, 2007, Pages 126-128

  Craig, David ^a,b   Donnelly, Caroline ^a   Hart, Dominic ^a   Carson, Robyn ^a   Passmore, Peter ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b Whitla Medical Building ^*  (United Kingdom)

Author keywords

5HT 2A; Alzheimer's disease; Polymorphism; Psychosis; Serotonin

Indexed keywords

CYTOSINE; SEROTONIN; SEROTONIN 2A RECEPTOR; THYMINE;

5 HT2A GENE; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DELUSION; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMISSION; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PSYCHOSIS; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

AGED; ALZHEIMER DISEASE; COHORT STUDIES; DELUSIONS; FEMALE; HUMANS; MALE; NORTHERN IRELAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; RECEPTOR, SEROTONIN, 5-HT2A;

EID: 33846289947     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30409     Document Type: Article

References (25)

1. Assal F, Cummings JL. 2002. Neuropsychiatric symptoms in the dementias. Curr Opin Neurol 15:445-450.
2. Assal F, Alarcon M, Solomon EC, Masterman D, Geschwind DH, Cummings JL. 2004. Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease. Arch Neurol 61:1249-1253.
3. Bacanu SA, Devlin B, Chowdari KV, DeKosky ST, Nimgaonkar VL, Sweet RA. 2002. Linkage analysis of Alzheimer disease with psychosis. Neurology 59:118-120.
4. Bray NJ, Buckland PR, Hall H, Owen MJ, O'Donovan MC. 2004. The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain. Mol Psychiatry 9:109-114.
5. Chicago, Ill. 2000. Statistical product and service solutions. Version 10.0. Chicago, Ill: SPSS Inc.
6. Craig D, Mirakhur A, Hart DJ, McIlroy SP, Passmore AP. 2005. A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease. Am J Geriatr Psychiatry 13:460-468.
7. Devanand DP, Jacobs DM, Tang MX, et al. 1997. The course of psychopathologic features in mild to moderate Alzheimer disease. Arch Gen Psychiatry 54:257-263.
8. Donaldson C, Tarrier N, Burns A. 1997. The impact of the symptoms of dementia on caregivers. Br J Psychiatry 170:62-68.
9. Donaldson C, Tarrier N, Burns A. 1998. Determinants of carer stress in Alzheimer's disease. Int J Geriatr Psychiatry 13:248-256.
10. Engelborghs S, Holmes C, McCulley M, De Deyn PP. 2004. 5-HT2A receptor polymorphism may modulate antipsychotic treatment response in Alzheimer's disease. Int J Geriatr Psychiatry 19:1108-1109.
11. Haupt M, Kurz A, Janner M. 2000. A 2-year follow-up of behavioural and psychological symptoms in Alzheimer's Disease. Dement Geriatr Cogn Disord 11:147-152.
12. Holmes C. 2000. Contribution of gentics to the understanding of behavioural and psychological symptoms of dementia. Int Psychogeriatr 12(Suppl 1): 83-88.
13. Holmes C, Arranz MJ, Powell JF, Collier DA, Lovestone S. 1998. 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. Hum Mol Genet 7:1507-1509.
14. Kaufer DI, Cummings JL, Christine D, et al. 1998. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: The Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc 46:210-215.
15. Lam LC, Tang NL, Ma SL, Zhang W, Chiu HF. 2004. 5-HT2A T102C receptor polymorphism and neuropsychiatric symptoms in Alzheimer's disease. Int J Geriatr Psychiatry 19:523-526.
16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944.
17. Nacmias B, Tedde A, Forleo P, et al. 2001. Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease. Biol Psychiatry 50:472-475.
18. Polesskaya OO, Sokolov BP. 2002. Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J Neurosci Res 67:812-822.
19. Prasad S, Semwal P, Deshpande S, Bhatia T, Nimgaonkar VL, Thelma BK. 2002. Molecular genetics of schizophrenia: Past, present and future. J Biosci 27:35-52.
20. Rocchi A, Micheli D, Ceravolo R, Manca ML, Tognoni G, Siciliano G, Murri L. 2003. Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): Association studies with psychosis in Alzheimer disease. Genet Test 7:309-314.
21. Ropacki SA, Jeste DV. 2005. Epidemiology of and risk factors for psychosis of Alzheimer's disease: A review of 55 studies published from 1990 to 2003. Am J Psychiatry 162:2022-2030.
22. Sweet RA, Pollock BG, Sukonick DL, et al. 2001. The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease. Int Psychogeriatr 13:401-409.
23. Warren JT Jr, Peacock ML, Rodriguez LC, Fink JK. 1993. An MspI polymorphism in the hyman serotonin receptor gene (HTR2): Detection by DGGE and RFLP analysis. Hum Mol Genet 2:338.
24. Williams J, McGuffin P, Nothen M, Owen MJ. 1997. Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia. Lancet 349:1221-1226.
25. Yu YW, Tsai SJ, Yang KH, Lin CH, Chen MC, Hong CJ. 2001. Evidence for an association between polymorphism in the serotonin-2A receptor variant (102T/C) and increment of N100 amplitude in schizophrenics treated with clozapine. Neuropsychobiology 43:79-82.